Glomus jugulare tumor: Tumor control and complications after stereotactic radiosurgery
Robert L. Foote(Mayo Clinic), Kerry D. Olsen(Mayo Clinic), Deborah A. Gorman(Mayo Clinic), Robert W. Kline(Mayo Clinic in Arizona), Jan L. Kasperbauer(Mayo Clinic), Michael J. Link(Mayo Clinic), Scott L. Stafford(Mayo Clinic in Arizona), Bruce E. Pollock(Mayo Clinic), Paula J. Schomberg(WinnMed), Scott E. Strome(Northwestern Medicine Lake Forest Hospital)
Cited by 158
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767